Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1101115.RA2cAlCePHQYSk0J-nNe964cRUNG0nkI4xTnJgwcPnNco130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1101115.RA2cAlCePHQYSk0J-nNe964cRUNG0nkI4xTnJgwcPnNco130_assertion type Assertion NP1101115.RA2cAlCePHQYSk0J-nNe964cRUNG0nkI4xTnJgwcPnNco130_head.
- NP1101115.RA2cAlCePHQYSk0J-nNe964cRUNG0nkI4xTnJgwcPnNco130_assertion description "[Here we demonstrate that about 20% of cases of LKS, CSWSS and electroclinically atypical rolandic epilepsy often associated with speech impairment can have a genetic origin sustained by de novo or inherited mutations in the GRIN2A gene (encoding the N-methyl-D-aspartate (NMDA) glutamate receptor ?2 subunit, GluN2A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1101115.RA2cAlCePHQYSk0J-nNe964cRUNG0nkI4xTnJgwcPnNco130_provenance.
- NP1101115.RA2cAlCePHQYSk0J-nNe964cRUNG0nkI4xTnJgwcPnNco130_assertion evidence source_evidence_literature NP1101115.RA2cAlCePHQYSk0J-nNe964cRUNG0nkI4xTnJgwcPnNco130_provenance.
- NP1101115.RA2cAlCePHQYSk0J-nNe964cRUNG0nkI4xTnJgwcPnNco130_assertion SIO_000772 23933820 NP1101115.RA2cAlCePHQYSk0J-nNe964cRUNG0nkI4xTnJgwcPnNco130_provenance.
- NP1101115.RA2cAlCePHQYSk0J-nNe964cRUNG0nkI4xTnJgwcPnNco130_assertion wasDerivedFrom befree-2016 NP1101115.RA2cAlCePHQYSk0J-nNe964cRUNG0nkI4xTnJgwcPnNco130_provenance.
- NP1101115.RA2cAlCePHQYSk0J-nNe964cRUNG0nkI4xTnJgwcPnNco130_assertion wasGeneratedBy ECO_0000203 NP1101115.RA2cAlCePHQYSk0J-nNe964cRUNG0nkI4xTnJgwcPnNco130_provenance.